Hyderabad-based GVK Biosciences, one of Asia’s leading drug discovery research & development organizations, announced that Astellas Pharma Inc. extended and renewed its license to the GVK BIO SAR Databases (GOSTAR).
GOSTAR (GVK BIO Online Structure Activity Relationship (SAR) Database) is an online scientific database product of GVK BIO. It integrates information on compounds from discovery & development stages and marketed drugs. Information provided includes SAR, ADME, toxicity, preclinical, clinical and structural data for over 5.1 million compounds and 16.7 million SAR points.
“We are excited that Astellas has decided to extend the license to the GOSTAR database. The GOSTAR database is becoming an indispensible tool for scientists in drug discovery. Several publications that have used the GOSTAR data validate the utility of this product,” said Sreeni Devidas, vice president, sales & marketing, informatics, GVK BIO.
The Informatics division is responsible for analyzing data to transform chemical/biological patterns into knowledge. Informatics offers custom curation, cheminformatics and bioinformatics services to global clients. It also licenses and sells databases to biotech and pharma companies.
GVK Biosciences is Asia’s leading discovery research and development organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain.
Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.